federal_register: 2025-04978
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04978 | Nonprescription Drug Product With an Additional Condition for Nonprescription Use | Rule | In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) was delayed until March 21, 2025. Additional time is needed for review; therefore, the delay is extended for an additional 60 days. | 2025-03-25 | 2025 | 3 | https://www.federalregister.gov/documents/2025/03/25/2025-04978/nonprescription-drug-product-with-an-additional-condition-for-nonprescription-use | https://www.govinfo.gov/content/pkg/FR-2025-03-25/pdf/2025-04978.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use,"... |